BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wahane A, Waghmode A, Kapphahn A, Dhuri K, Gupta A, Bahal R. Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy. Molecules 2020;25:E2866. [PMID: 32580326 DOI: 10.3390/molecules25122866] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Du M, Wang T, Yang Y, Zeng F, Li Y, Chen Z, Haug AR. Application of Genetically Encoded Molecular Imaging Probes in Tumor Imaging. Contrast Media & Molecular Imaging 2022;2022:1-9. [DOI: 10.1155/2022/5473244] [Reference Citation Analysis]
2 Tsakiri M, Zivko C, Demetzos C, Mahairaki V. Lipid-based nanoparticles and RNA as innovative neuro-therapeutics. Front Pharmacol 2022;13:900610. [DOI: 10.3389/fphar.2022.900610] [Reference Citation Analysis]
3 Yadav K, Singh D, Singh MR, Minz S, Sahu KK, Kaurav M, Pradhan M. Dermal nanomedicine: Uncovering the ability of nucleic acid to alleviate autoimmune and other related skin disorders. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103437] [Reference Citation Analysis]
4 Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, Sharf-Pauker N, Xiao Y, Adir O, Liang H, Shi J, Schroeder A, Conde J. Nanodelivery of nucleic acids. Nat Rev Methods Primers 2022;2:24. [PMID: 35480987 DOI: 10.1038/s43586-022-00104-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Schoser B. [Principles of translational gene therapy for neuromuscular diseases]. Nervenarzt 2022. [PMID: 35384490 DOI: 10.1007/s00115-022-01287-1] [Reference Citation Analysis]
6 Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther 2022;7:94. [PMID: 35322018 DOI: 10.1038/s41392-022-00950-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
7 Liu Y, Yang H, Liu Q, Pan M, Wang D, Pan S, Zhang W, Wei J, Zhao X, Ji J. Selenocystine-Derived Label-Free Fluorescent Schiff Base Nanocomplex for siRNA Delivery Synergistically Kills Cancer Cells. Molecules 2022;27:1302. [PMID: 35209090 DOI: 10.3390/molecules27041302] [Reference Citation Analysis]
8 Angelini G, Mura G, Messina G. Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies. Exp Cell Res 2022;410:112968. [PMID: 34883113 DOI: 10.1016/j.yexcr.2021.112968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Hauck ES, Hecker JG. Non-Viral Delivery of RNA Gene Therapy to the Central Nervous System. Pharmaceutics 2022;14:165. [PMID: 35057059 DOI: 10.3390/pharmaceutics14010165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Helms AS, Thompson AD, Day SM. Translation of New and Emerging Therapies for Genetic Cardiomyopathies. JACC Basic Transl Sci 2022;7:70-83. [PMID: 35128211 DOI: 10.1016/j.jacbts.2021.07.012] [Reference Citation Analysis]
11 Ouranidis A, Vavilis T, Mandala E, Davidopoulou C, Stamoula E, Markopoulou CK, Karagianni A, Kachrimanis K. mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 2022;10:50. [DOI: 10.3390/biomedicines10010050] [Reference Citation Analysis]
12 Jerzykiewicz J, Czogalla A. Polyethyleneimine-Based Lipopolyplexes as Carriers in Anticancer Gene Therapies. Materials (Basel) 2021;15:179. [PMID: 35009324 DOI: 10.3390/ma15010179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jafari M, Rahimi N, Jami MS, Hashemzadeh Chaleshtori M, Elahian F, Mirzaei SA. Silencing of α-N-acetylgalactosaminidase in the gastric cancer cells amplified cell death and attenuated migration, while the multidrug resistance remained unchanged. Cell Biol Int 2021. [PMID: 34816536 DOI: 10.1002/cbin.11727] [Reference Citation Analysis]
14 Balmayor ER. Synthetic mRNA - emerging new class of drug for tissue regeneration. Curr Opin Biotechnol 2021;74:8-14. [PMID: 34749063 DOI: 10.1016/j.copbio.2021.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Niu L, Chen G, Feng Y, Liu X, Pan P, Huang L, Guo Y, Li M. Polyethylenimine-Modified Bombyx mori Silk Fibroin as a Delivery Carrier of the ING4-IL-24 Coexpression Plasmid. Polymers (Basel) 2021;13:3592. [PMID: 34685354 DOI: 10.3390/polym13203592] [Reference Citation Analysis]
16 Wahane A, Malik S, Shih KC, Gaddam RR, Chen C, Liu Y, Nieh MP, Vikram A, Bahal R. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy. ACS Appl Mater Interfaces 2021;13:45244-58. [PMID: 34524806 DOI: 10.1021/acsami.1c11981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Richter F, Leer K, Martin L, Mapfumo P, Solomun JI, Kuchenbrod MT, Hoeppener S, Brendel JC, Traeger A. The impact of anionic polymers on gene delivery: how composition and assembly help evading the toxicity-efficiency dilemma. J Nanobiotechnology 2021;19:292. [PMID: 34579715 DOI: 10.1186/s12951-021-00994-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Piperno A, Sciortino MT, Giusto E, Montesi M, Panseri S, Scala A. Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles. Int J Nanomedicine 2021;16:5981-6002. [PMID: 34511901 DOI: 10.2147/IJN.S321329] [Reference Citation Analysis]
19 Shtykalova SV, Egorova AA, Maretina MA, Freund SA, Baranov VS, Kiselev AV. Molecular Genetic Basis and Prospects of Gene Therapy of Uterine Leiomyoma. Russ J Genet 2021;57:1002-16. [DOI: 10.1134/s1022795421090118] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zohri M, Arefian E, Akbari Javar H, Gazori T, Aghaee-Bakhtiari SH, Taheri M, Fatahi Y, Azadi A, Khoshayand MR, Ghahremani MH. Potential of chitosan/alginate nanoparticles as a non-viral vector for gene delivery: Formulation and optimization using D-optimal design. Mater Sci Eng C Mater Biol Appl 2021;128:112262. [PMID: 34474821 DOI: 10.1016/j.msec.2021.112262] [Reference Citation Analysis]
21 Meyer T, Sand M, Schmitz L, Stockfleth E. The Role of Circular RNAs in Keratinocyte Carcinomas. Cancers (Basel) 2021;13:4240. [PMID: 34439394 DOI: 10.3390/cancers13164240] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Huang Y, Wang L, Chen Y, Han H, Li Q. Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy. Molecules 2021;26:4827. [PMID: 34443415 DOI: 10.3390/molecules26164827] [Reference Citation Analysis]
23 Saeed RM, Abdullah M, Ahram M, Taha MO. Novel Ellipsoid Chitosan-Phthalate Lecithin Nanoparticles for siRNA Delivery. Front Bioeng Biotechnol 2021;9:695371. [PMID: 34395401 DOI: 10.3389/fbioe.2021.695371] [Reference Citation Analysis]
24 Zhang Y, Sun C, Wang C, Jankovic KE, Dong Y. Lipids and Lipid Derivatives for RNA Delivery. Chem Rev 2021. [PMID: 34279087 DOI: 10.1021/acs.chemrev.1c00244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yang Y, Fu Y, Tang Q, Luo Q, Li M. Preparation of Double-Layer Nanoparticles for Inhibitory Efficiency in Vascular Restenosis via Balloon Infusion. sci adv mater 2021;13:1335-43. [DOI: 10.1166/sam.2021.4040] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Delehedde C, Even L, Midoux P, Pichon C, Perche F. Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles. Pharmaceutics 2021;13:945. [PMID: 34202584 DOI: 10.3390/pharmaceutics13070945] [Reference Citation Analysis]
27 Sharma D, Arora S, Singh J, Layek B. A review of the tortuous path of nonviral gene delivery and recent progress. Int J Biol Macromol 2021;183:2055-73. [PMID: 34087309 DOI: 10.1016/j.ijbiomac.2021.05.192] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Dhuri K, Vyas RN, Blumenfeld L, Verma R, Bahal R. Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy. Cells 2021;10:1011. [PMID: 33922958 DOI: 10.3390/cells10051011] [Reference Citation Analysis]
29 Cai J, Qi H, Yao K, Yao Y, Jing D, Liao W, Zhao Z. Non-Coding RNAs Steering the Senescence-Related Progress, Properties, and Application of Mesenchymal Stem Cells. Front Cell Dev Biol 2021;9:650431. [PMID: 33816501 DOI: 10.3389/fcell.2021.650431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kim J, Eygeris Y, Gupta M, Sahay G. Self-assembled mRNA vaccines. Adv Drug Deliv Rev 2021;170:83-112. [PMID: 33400957 DOI: 10.1016/j.addr.2020.12.014] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 79.0] [Reference Citation Analysis]
31 Andreana I, Repellin M, Carton F, Kryza D, Briançon S, Chazaud B, Mounier R, Arpicco S, Malatesta M, Stella B, Lollo G. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics 2021;13:278. [PMID: 33669654 DOI: 10.3390/pharmaceutics13020278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Sato Y, Nakamura T, Yamada Y, Harashima H. The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS. Journal of Controlled Release 2021;330:305-16. [DOI: 10.1016/j.jconrel.2020.12.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
33 Pennetta C, Bono N, Ponti F, Bellucci MC, Viani F, Candiani G, Volonterio A. Multifunctional Neomycin-Triazine-Based Cationic Lipids for Gene Delivery with Antibacterial Properties. Bioconjug Chem 2021;32:690-701. [PMID: 33470802 DOI: 10.1021/acs.bioconjchem.0c00616] [Reference Citation Analysis]
34 Buschmann MD, Carrasco MJ, Alishetty S, Paige M, Alameh MG, Weissman D. Nanomaterial Delivery Systems for mRNA Vaccines. Vaccines (Basel) 2021;9:65. [PMID: 33478109 DOI: 10.3390/vaccines9010065] [Cited by in Crossref: 138] [Cited by in F6Publishing: 112] [Article Influence: 138.0] [Reference Citation Analysis]
35 Ulkoski D, Munson MJ, Jacobson ME, Palmer CR, Carson CS, Sabirsh A, Wilson JT, Krishnamurthy VR. High-Throughput Automation of Endosomolytic Polymers for mRNA Delivery. ACS Appl Bio Mater 2021;4:1640-54. [DOI: 10.1021/acsabm.0c01463] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
36 Stevens DM, Crist RM, Stern ST. Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine. Molecules 2020;26:E175. [PMID: 33396545 DOI: 10.3390/molecules26010175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Heslop E, Turner C, Irvin A, Muntoni F, Straub V, Guglieri M; workshop participants. Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead. Neuromuscul Disord 2021;31:69-78. [PMID: 33158687 DOI: 10.1016/j.nmd.2020.10.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Guevara ML, Persano F, Persano S. Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy. Front Chem 2020;8:589959. [PMID: 33195094 DOI: 10.3389/fchem.2020.589959] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
39 Wang Y, Wagner E. Non-Viral Targeted Nucleic Acid Delivery: Apply Sequences for Optimization. Pharmaceutics 2020;12:E888. [PMID: 32961908 DOI: 10.3390/pharmaceutics12090888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
40 Malik S, Lim J, Slack FJ, Braddock DT, Bahal R. Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles. J Control Release 2020;327:406-19. [PMID: 32835710 DOI: 10.1016/j.jconrel.2020.08.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
41 Qiao L, Qin Y, Wang Y, Liang Y, Zhu D, Xiong W, Li L, Bao D, Zhang L, Jin X. A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles. RSC Adv 2020;10:41471-81. [DOI: 10.1039/d0ra07161g] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]